HemoSonics, LLC is breaking new ground in point-of-care Viscoelastic #hemostasis testing. When time is critical, the Quantra® QPlus® System offers rapid, accurate, and easy to understand results that enable clinicians to make more informed #transfusion decisions, more quickly. This novel, cartridge-based POC VET system now has De Novo marketing authorization in the USA and is intended to assess the coagulation status of perioperative patients at the point of care.
Follow us at @HemoSonics
Location: United States, Virginia, Charlottesville
Employees: 51-200
Founded date: 2004
Investors 1
| Date | Name | Website |
| - | UVA Licens... | lvg.virgin... |
Mentions in press and media 6
| Date | Title | Description | Source |
| 26.10.2021 | What Innovation Works’ life sciences director sees for the i... | Megan Shaw loves the excitement of the startup world. That enthusiasm would lead down a path toward... | technical.... |
| 23.10.2014 | Three of these nine innovative technologies are Ben Companie... | Gene silencing technology as a cancer treatment and diagnostics to predict which colon cancer pati... | sep.benfra... |
| 11.06.2013 | Diagnostic to assess clotting disorders in surgery raises ne... | Last fall, the Charlottesville, Virginia-based medical device company enlisted Cambridge Consultants... | medcitynew... |
| 21.09.2012 | Diagnostic device uses ultrasound to assess risk of excessiv... | Walker said the company will use the funding to finish product development and initiate clinical stu... | medcitynew... |
| - | Diagnostic device uses ultrasound to assess risk of excessiv... | A diagnostic device could speed up and take the guesswork out of diagnosing and guiding treatment fo... | medcitynew... |
| - | Diagnostic to assess clotting disorders in surgery raises ne... | A medical device company has raised nearly $1.3 million to advance a diagnostic to detect life-threa... | medcitynew... |